SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-021575
Filing Date
2020-05-06
Accepted
2020-05-06 09:16:32
Documents
56
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hrtx-10q_20200331.htm   iXBRL 10-Q 1827682
2 EX-31.1 hrtx-ex311_7.htm EX-31.1 18385
3 EX-31.2 hrtx-ex312_8.htm EX-31.2 18447
4 EX-32.1 hrtx-ex321_6.htm EX-32.1 17184
  Complete submission text file 0001564590-20-021575.txt   6423193

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20200331.xsd EX-101.SCH 33952
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20200331_cal.xml EX-101.CAL 42364
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20200331_def.xml EX-101.DEF 104617
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20200331_lab.xml EX-101.LAB 304482
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20200331_pre.xml EX-101.PRE 220534
10 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-10q_20200331_htm.xml XML 1296718
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 20851430
SIC: 2834 Pharmaceutical Preparations